Skip to main content
Premium Trial:

Request an Annual Quote

BD, Breakout Labs Partner on Funding, Guidance to Startups

NEW YORK (GenomeWeb) – Becton Dickinson and Breakout Labs today announced a strategic relationship in which BD will provide funding and guidance to selected start-ups in Breakout's portfolio. 

Breakout, a philanthropic fund for early-stage science and technology firms, is a program of the Thiel Foundation. 

BD will periodically review Breakout's portfolio for firms that are developing technologies relevant to BD's medical and life science business segments. Those selected by BD will receive up to $25,000 in funding, as well as a business mentor to provide guidance and connections, the partners said. 

CytoVale has received a grant for an undisclosed amount in a pilot run of the partnership. Also, Andrea Liebmann-Vinson at BD's Corporate Innovation Center in Research Triangle Park, NC, will provide expertise to CytoVale in technical evaluations, as well as in regulatory, reimbursement, and manufacturing operations. 

CytoVale was founded in 2013 to commercialize technology developed at the University of California, Los Angeles. Its platform is based on microfluidic technologies for high-throughput single-cell analysis and is being used in a range of clinical diagnostic applications, BD and Breakout said.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.